Intuitive Surgical, Inc. (ISRG) Posts Q1 EPS of $1.13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Intuitive Surgical (ISRG) Remains Outperform at Barrington Despite Deceleration
April 23, 2014 3:26 PM EDTBarrington Research maintained an Outperform rating on Intuitive Surgical (NASDAQ: ISRG) with a price target of $650. Analyst Charley R. Jones noted that guidance reflects deceleration but he is a buyer on weakness.
"ISRG reported weaker-than-expected Q1/14 results and guidance for the remainder... More
Intuitive Surgical (ISRG) Q1 'a Bust' - Northland Capital Markets
April 23, 2014 8:26 AM EDTNorthland Capital Markets analyst Suraj Kalia reiterated an Underperform rating and $275 price target on Intuitive Surgical (NASDAQ: ISRG) calling Q1 'a bust.'
Kalia commented, "Intuitive's Q1-14 call yesterday had some ominous signs of a different story moving forward. Revs @ $465M completely... More
Intuitive Surgical (ISRG) Target, Estimates Slashed at Jefferies Post Q1; 'Buy' Maintained
April 23, 2014 7:01 AM EDTJefferies analyst Imron Zafar cut estimates and his price target on Intuitive Surgical (NASDAQ: ISRG) from $595 to $465 following weak Q1 results.
Zafar states, "1Q was weak across the board, and while a procedure guidance... More
Intuitive Surgical, Inc. (ISRG) Receives FDA 510(k) Clearance of da Vinci Sp Surgical System
April 22, 2014 8:31 AM EDTIntuitive Surgical, Inc. (Nasdaq: ISRG) announced it has received FDA 510(k) clearance for the da Vinci Sp Surgical System, which is designed to expand the Company's single-incision product offering. This initial clearance is specific to urologic surgical procedures that are appropriate for a... More

